MMR vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles).
| |
MMR vaccine
| |
| Combination of | |
| Measles vaccine | Vaccine |
| Mumps vaccine | Vaccine |
| Rubella vaccine | Vaccine |
| Identifiers | |
| CAS number | ? |
| ATC code | J07BD52 |
| PubChem | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
℞ Prescription only |
| Routes | ? |
The first dose is given to children around 9 to 15 months of age, with a second dose at 15 months o 6 years of age, with at least 4 weeks between the doses.[1][2] After two doses 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella.[1]
The World Health Organisation sets a target of 95% needed to achieve and sustain measles elimination. In 2020/1 only 85.5% of five-year-olds in England were vaccinated.[3]
The vaccine is also recommended in those who do not have evidence of immunity,[1] and those with well controlled HIV/AIDS.[4][5] It is given by injection.[1]
MMR Vaccine Media
Measles cases reported in the United States fell drastically after the introduction of the measles vaccine.
Rubella rates fell sharply in the United States when immunization was introduced.
Maurice Hilleman, who developed the MMR vaccine
Two workers make openings in chicken eggs in preparation for a measles vaccine
References
- ↑ 1.0 1.1 1.2 1.3 MMR Vaccination What You Should Know Measles, Mumps, Rubella (in en-us). CDC (2 February 2018). Retrieved 10 September 2018.
- ↑ Measles vaccines: WHO position paper – April 2017. Releve Epidemiologique Hebdomadaire 92 (17) (28 April 2017). p. 205–27.
- ↑ A Fresh Shot (in en). Policy Exchange. Retrieved 2023-10-20.
- ↑ Kinney, Rebecca. Core Concepts - Immunizations in Adults - Basic HIV Primary Care - National HIV CurriculumImmunizations in Adults (in en). www.hiv.uw.edu (2 May 2017).
- ↑ Watson, JC. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports 47 (RR-8) (22 May 1998). p. 1–57.
